Literature DB >> 17531915

Risk-factor clustering and cardiovascular disease risk in hypertensive patients.

Derek Weycker1, Gregory A Nichols, Maureen O'Keeffe-Rosetti, John Edelsberg, Zeba M Khan, Satyin Kaura, Gerry Oster.   

Abstract

BACKGROUND: Patients with hypertension often have other major risk factors for cardiovascular disease (CVD). Little is known, however, about the extent of risk-factor clustering in these patients and its importance in CVD risk and medical-care costs.
METHODS: Study subjects were selected from the electronic medical records system of Kaiser Permanente Northwest, a large health maintenance organization, and included all patients aged > or =35 years with hypertension who were free of CVD in 1998. Subjects were stratified into eight risk-factor clusters based on whether or not they also had diabetes, hyperlipidemia, or a high body mass index (BMI). The risk of cardiovascular events was examined in each cluster over 6 years beginning January 1, 1999, using Kaplan-Meier methods and Cox proportional hazards models. Cumulative total medical-care costs (per patient) over 6 years also were examined.
RESULTS: A total of 57,573 patients with hypertension who were free of CVD in 1998 were identified; 56% of subjects also had diabetes, hyperlipidemia, or high BMI. In analyses controlling for age, sex, and smoking status, the relative risk of cardiovascular events over 6 years was highest for patients with comorbid diabetes, ranging from 2.07 (95% confidence interval, 1.86-2.30) for those with diabetes only to 2.80 (95% confidence interval, 2.48-3.17) for those with diabetes, hyperlipidemia, and high BMI. Cumulative medical-care costs generally increased with additional risk factors. Comorbid diabetes had the greatest impact on costs over 6 years.
CONCLUSIONS: More than 50% of patients with hypertension also had diabetes, hyperlipidemia, or high BMI. Patients with these additional risk factors (especially diabetes) had a substantially higher CVD risk and medical-care costs.

Entities:  

Mesh:

Year:  2007        PMID: 17531915     DOI: 10.1016/j.amjhyper.2006.10.013

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  21 in total

1.  Cost-of-illness studies: a guide to critical evaluation.

Authors:  Allison Larg; John R Moss
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

2.  HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction.

Authors:  Anne-Lise Paisible; Chung-Chou H Chang; Kaku A So-Armah; Adeel A Butt; David A Leaf; Matthew Budoff; David Rimland; Roger Bedimo; Matthew B Goetz; Maria C Rodriguez-Barradas; Heidi M Crane; Cynthia L Gibert; Sheldon T Brown; Hilary A Tindle; Alberta L Warner; Charles Alcorn; Melissa Skanderson; Amy C Justice; Matthew S Freiberg
Journal:  J Acquir Immune Defic Syndr       Date:  2015-02-01       Impact factor: 3.731

3.  Hypertension and Health-Related Quality of Life (HRQoL): Evidence from the US Hispanic Population.

Authors:  Elizabeth Riley; Jongwha Chang; Chanhyun Park; Sean Kim; Inho Song
Journal:  Clin Drug Investig       Date:  2019-09       Impact factor: 2.859

4.  Global Risk Assessment to Guide Blood Pressure Management in Cardiovascular Disease Prevention.

Authors:  Kunal N Karmali; Donald M Lloyd-Jones
Journal:  Hypertension       Date:  2017-01-23       Impact factor: 10.190

5.  Effect of cardiometabolic risk factors on hypertension management: a cross-sectional study among 28 physician practices in the United States.

Authors:  Daniel A Belletti; Christopher Zacker; Jenifer Wogen
Journal:  Cardiovasc Diabetol       Date:  2010-02-01       Impact factor: 9.951

6.  Beta-blocker use is associated with lower stroke and death after carotid artery stenting.

Authors:  Tammam Obeid; Isibor Arhuidese; Alicia Gaidry; Umair Qazi; Christopher Abularrage; Philip Goodney; Jack Cronenwett; Mahmoud Malas
Journal:  J Vasc Surg       Date:  2015-10-30       Impact factor: 4.268

7.  Racial disparity in hypertension control: tallying the death toll.

Authors:  Kevin Fiscella; Kathleen Holt
Journal:  Ann Fam Med       Date:  2008 Nov-Dec       Impact factor: 5.166

8.  Mortality and cardiovascular risk in patients with a history of malignant hypertension: a case-control study.

Authors:  Fouad Amraoui; Niels V Van Der Hoeven; Irene G M Van Valkengoed; Liffert Vogt; Bert-Jan H Van Den Born
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-12-27       Impact factor: 3.738

Review 9.  Blood pressure control in patients with comorbidities.

Authors:  Roland E Schmieder; Luis M Ruilope
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-08       Impact factor: 3.738

Review 10.  Prompt, aggressive BP lowering in high-risk patients.

Authors:  Kenneth A Jamerson; Jan Basile
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.